SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5ยข to $5 -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (19356)4/4/2004 11:34:18 AM
From: Chris Forte  Respond to of 120405
 
rrufff, regarding CTE I couldn't agree more...

I like the fact that it is not a one-trick pony - CABG, stents (with IMX), sterile wound dressings. They make money while in development, which is rare.

I think you hit the nail on the head. The big kahuna for CTE is the synthetic coronary bypass grafts, but they have other irons in the developmental fire. And like you said, they also have sales of existing products as a nice foundation.

Chris


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News